Búsqueda | Biblioteca Virtual en Salud

1.

Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.

Hurvitz, Sara A; Bardia, Aditya; Quiroga, Vanesa; Park, Yeon Hee; Blancas, Isabel; Alonso-Romero, José Luis; Vasiliev, Aleksandr; Adamchuk, Hryhoriy; Salgado, Marcelo; Yardley, Denise A; Berzoy, Oleksandr; Zamora-Auñón, Pilar; Chan, David; Spera, Gonzalo; Xue, Cloris; Ferreira, Erika; Badovinac Crnjevic, Tanja; Pérez-Moreno, Pablo Diego; López-Valverde, Vanesa; Steinseifer, Jutta; Fernando, Tharu M; Moore, Heather M; Fasching, Peter A.

Lancet Oncol ; 24(9): 1029-1041, 2023 09.

Artículo en Inglés | MEDLINE | ID: mdl-37657462

2.

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.

Tan, Antoinette R; Im, Seock-Ah; Mattar, André; Colomer, Ramon; Stroyakovskii, Daniil; Nowecki, Zbigniew; De Laurentiis, Michelino; Pierga, Jean-Yves; Jung, Kyung Hae; Schem, Christian; Hogea, Alexandra; Badovinac Crnjevic, Tanja; Heeson, Sarah; Shivhare, Mahesh; Kirschbrown, Whitney P; Restuccia, Eleonora; Jackisch, Christian.

Lancet Oncol ; 22(1): 85-97, 2021 01.

Artículo en Inglés | MEDLINE | ID: mdl-33357420

3.

Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial.

Krop, Ian E; Kim, Sung-Bae; Martin, Antonio Gonzalez; LoRusso, Patricia M; Ferrero, Jean-Marc; Badovinac-Crnjevic, Tanja; Hoersch, Silke; Smitt, Melanie; Wildiers, Hans.

Lancet Oncol ; 18(6): 743-754, 2017 06.

Artículo en Inglés | MEDLINE | ID: mdl-28526538

4.

Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14.

Chapman, Judith-Anne W; Sgroi, Dennis C; Goss, Paul E; Zarella, Elizabeth; Binns, Shemeica; Zhang, Yi; Schnabel, Catherine A; Erlander, Mark G; Pritchard, Kathleen I; Han, Lei; Badovinac-Crnjevic, Tanja; Shepherd, Lois E; Pollak, Michael N.

Breast Cancer Res Treat ; 157(1): 101-8, 2016 05.

Artículo en Inglés | MEDLINE | ID: mdl-27116182

5.

Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.

Goss, Paul E; Hershman, Dawn L; Cheung, Angela M; Ingle, James N; Khosla, Sundeep; Stearns, Vered; Chalchal, Haji; Rowland, Kendrith; Muss, Hyman B; Linden, Hannah M; Scher, Judite; Pritchard, Kathleen I; Elliott, Catherine R; Badovinac-Crnjevic, Tanja; St Louis, Jessica; Chapman, Judith-Anne W; Shepherd, Lois E.

Lancet Oncol ; 15(4): 474-82, 2014 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-24636210

6.

Challenges to effective cancer control in China, India, and Russia.

Goss, Paul E; Strasser-Weippl, Kathrin; Lee-Bychkovsky, Brittany L; Fan, Lei; Li, Junjie; Chavarri-Guerra, Yanin; Liedke, Pedro E R; Pramesh, C S; Badovinac-Crnjevic, Tanja; Sheikine, Yuri; Chen, Zhu; Qiao, You-lin; Shao, Zhiming; Wu, Yi-Long; Fan, Daiming; Chow, Louis W C; Wang, Jun; Zhang, Qiong; Yu, Shiying; Shen, Gordon; He, Jie; Purushotham, Arnie; Sullivan, Richard; Badwe, Rajendra; Banavali, Shripad D; Nair, Reena; Kumar, Lalit; Parikh, Purvish; Subramanian, Somasundarum; Chaturvedi, Pankaj; Iyer, Subramania; Shastri, Surendra Srinivas; Digumarti, Raghunadhrao; Soto-Perez-de-Celis, Enrique; Adilbay, Dauren; Semiglazov, Vladimir; Orlov, Sergey; Kaidarova, Dilyara; Tsimafeyeu, Ilya; Tatishchev, Sergei; Danishevskiy, Kirill D; Hurlbert, Marc; Vail, Caroline; St Louis, Jessica; Chan, Arlene.

Lancet Oncol ; 15(5): 489-538, 2014 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-24731404

7.

Planning cancer control in Latin America and the Caribbean.

Goss, Paul E; Lee, Brittany L; Badovinac-Crnjevic, Tanja; Strasser-Weippl, Kathrin; Chavarri-Guerra, Yanin; St Louis, Jessica; Villarreal-Garza, Cynthia; Unger-Saldaña, Karla; Ferreyra, Mayra; Debiasi, Márcio; Liedke, Pedro E R; Touya, Diego; Werutsky, Gustavo; Higgins, Michaela; Fan, Lei; Vasconcelos, Claudia; Cazap, Eduardo; Vallejos, Carlos; Mohar, Alejandro; Knaul, Felicia; Arreola, Hector; Batura, Rekha; Luciani, Silvana; Sullivan, Richard; Finkelstein, Dianne; Simon, Sergio; Barrios, Carlos; Kightlinger, Rebecca; Gelrud, Andres; Bychkovsky, Vladimir; Lopes, Gilberto; Stefani, Stephen; Blaya, Marcelo; Souza, Fabiano Hahn; Santos, Franklin Santana; Kaemmerer, Alberto; de Azambuja, Evandro; Zorilla, Andres Felipe Cardona; Murillo, Raul; Jeronimo, Jose; Tsu, Vivien; Carvalho, Andre; Gil, Carlos Ferreira; Sternberg, Cinthya; Dueñas-Gonzalez, Alfonso; Sgroi, Dennis; Cuello, Mauricio; Fresco, Rodrigo; Reis, Rui Manuel; Masera, Guiseppe.

Lancet Oncol ; 14(5): 391-436, 2013 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-23628188

8.

[Ultrasound guided breast biopsy--a retrospective study and literature review]. / Biopsija dojke pod kontrolom ultrazvuka--retrospektivna studija i pregled literature.

Prutki, Maja; Stern-Padovan, Ranka; Jakic-Razumovic, Jasminka; Potocki, Kristina; Badovinac-Crnjevic, Tanja; Golubic, Anja Tea.

Lijec Vjesn ; 134(9-10): 270-5, 2012.

Artículo en Hr | MEDLINE | ID: mdl-23297511

9.

Impact of Dose Delays and Alternative Dosing Regimens on Pertuzumab Pharmacokinetics.

Liu, Stephanie N; Lu, Tong; Jin, Jin Y; Li, Chunze; Girish, Sandhya; Melnikov, Fjodor; Badovinac Crnjevic, Tanja; Machackova, Zuzana; Restuccia, Eleonora; Kirschbrown, Whitney P.

J Clin Pharmacol ; 61(8): 1096-1105, 2021 08.

Artículo en Inglés | MEDLINE | ID: mdl-33719071

10.

Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

Wang, Bei; Deng, Rong; Hennig, Stefanie; Badovinac Crnjevic, Tanja; Kaewphluk, Monika; Kågedal, Matts; Quartino, Angelica L; Girish, Sandhya; Li, Chunze; Kirschbrown, Whitney P.

Cancer Chemother Pharmacol ; 88(3): 499-512, 2021 09.

Artículo en Inglés | MEDLINE | ID: mdl-34106303

11.

Development of a Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose-Finding Study.

Kirschbrown, Whitney P; Wynne, Chris; Kågedal, Matts; Wada, Russ; Li, Hanbin; Wang, Bei; Nijem, Ihsan; Badovinac Crnjevic, Tanja; Gasser, Helena; Heeson, Sarah; Eng-Wong, Jennifer; Garg, Amit.

J Clin Pharmacol ; 59(5): 702-716, 2019 05.

Artículo en Inglés | MEDLINE | ID: mdl-30570763

12.

Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.

Strasser-Weippl, Kathrin; Higgins, Michaela J; Chapman, Judith-Anne W; Ingle, James N; Sledge, George W; Budd, George T; Ellis, Matthew J; Pritchard, Kathleen I; Clemons, Mark J; Badovinac-Crnjevic, Tanja; Han, Lei; Gelmon, Karen A; Rabaglio, Manuela; Elliott, Catherine; Shepherd, Lois E; Goss, Paul E.

J Natl Cancer Inst ; 110(9): 1003-1008, 2018 09 01.

Artículo en Inglés | MEDLINE | ID: mdl-29554282

13.

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.

Matissek, Karina J; Onozato, Maristela L; Sun, Sheng; Zheng, Zongli; Schultz, Andrew; Lee, Jesse; Patel, Kristofer; Jerevall, Piiha-Lotta; Saladi, Srinivas Vinod; Macleay, Allison; Tavallai, Mehrad; Badovinac-Crnjevic, Tanja; Barrios, Carlos; Bese, Nuran; Chan, Arlene; Chavarri-Guerra, Yanin; Debiasi, Marcio; Demirdögen, Elif; Egeli, Ünal; Gökgöz, Sahsuvar; Gomez, Henry; Liedke, Pedro; Tasdelen, Ismet; Tolunay, Sahsine; Werutsky, Gustavo; St Louis, Jessica; Horick, Nora; Finkelstein, Dianne M; Le, Long Phi; Bardia, Aditya; Goss, Paul E; Sgroi, Dennis C; Iafrate, A John; Ellisen, Leif W.

Cancer Discov ; 8(3): 336-353, 2018 03.

Artículo en Inglés | MEDLINE | ID: mdl-29242214

14.

Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy.

Urruticoechea, Ander; Rizwanullah, Mohammed; Im, Seock-Ah; Ruiz, Antonio Carlos Sánchez; Láng, István; Tomasello, Gianluca; Douthwaite, Hannah; Badovinac Crnjevic, Tanja; Heeson, Sarah; Eng-Wong, Jennifer; Muñoz, Montserrat.

J Clin Oncol ; 35(26): 3030-3038, 2017 Sep 10.

Artículo en Inglés | MEDLINE | ID: mdl-28437161

15.

Correction to: Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

Wang, Bei; Deng, Rong; Hennig, Stefanie; Badovinac Crnjevic, Tanja; Kaewphluk, Monika; Kågedal, Matts; Quartino, Angelica L; Girish, Sandhya; Li, Chunze; Kirschbrown, Whitney P.

Cancer Chemother Pharmacol ; 89(4): 571-572, 2022 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-34559287

16.

Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer.

Strasser-Weippl, Kathrin; Badovinac-Crnjevic, Tanja; Fan, Lei; Goss, Paul E.

Breast ; 22 Suppl 2: S171-5, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-24074782

17.

High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer.

Badovinac Crnjevic, Tanja; Tanja, Badovinac Crnjevic; Spagnoli, Giulio; Giulio, Spagnoli; Juretic, Antonio; Antonio, Juretic; Jakic-Razumovic, Jasminka; Jasminka, Jakic-Razumovic; Podolski, Paula; Paula, Podolski; Saric, Nera; Nera, Saric.

Med Oncol ; 29(3): 1586-91, 2012 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-22116775

18.

Significance of epidermal growth factor receptor expression in breast cancer.

Badovinac-Crnjevic, Tanja; Jakic-Razumovic, Jasminka; Podolski, Paula; Plestina, Stjepko; Sarcevic, Bozena; Munjas, Radenka; Vrbanec, Damir.

Med Oncol ; 28 Suppl 1: S121-8, 2011 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-21104342

19.

Planning cancer control in Latin America and the Caribbean

Goss, Paul E; Lee, Brittany L; Badovinac Crnjevic, Tanja; Strasser Weippl, Kathrin; Chavarri Guerra, Yanin; St Louis, Jessica; Villareal Garza, Cynthia; Unger Saldaña, Karla; Ferreyra, Mayra; Debiasi, Marcio; Liedke, Pedro ER; Touyá, Diego; Werutsky, Gustavo; Higgins, Michaela; Fan, Lei; Vasconcelos, Claudia; Cazap, Eduardo; Vallejos, Carlos; Mohar, Alejandro; Knaul, Felicia; Arreola, Héctor; Batura, Rekha; Luciani, Silvana; Sullivan, Richard; Finkelstein, Dianne; Simon, Sergio; Barrios, Carlos; Kightlinger, Rebecca; Gelrud, Andrés; Bychkovsky, Vladimir; Lopes, Gilberto; Stefani, Stephen; Blaya, Marcelo; Hahn Souza, Fabiano; Santana Santos, Franklin; Kaemmerer, Alberto; Azambuja, Evandro de; Cardona Zorilla, Andrés Felipe; Murillo, Raúl; Jerónimo, José; Tsu, Vivien; Carvalho, Carlos; Ferreira Gil, Carlos; Stemberg, Cinthya; Dueñas González, Alfonso; Sgroi, Dennis; Cuello, Mauricio; Fresco, Rodrigo; Reis, Rui Manuel; Masera, Guiseppe; Gabús, Raúl; Ribeiro, Raúl; Knust, Renata; Ismael, Gustavo; Rosenblatt, Eduardo; Roth, Berta; Villa, Luisa; Solares, Argelia Lara; León, Marta Ximena; Torres Vigil, Isabel; Covarrubias Gomez, Alfredo; Hernández, Andrés; Bertolino, Mariela; Schwartsmann, Gilberto; Santillana, Sergio; Esteva, Francisco; Fein, Luis; Mano, Max; Gómez, Henry; Hurlbert, Marc; Durstine, Alessandra; Azenha, Gustavo.

Lancet Oncol ; 14: 391-436, abril, 2013. tab, map

Artículo en Inglés | URUCAN | ID: bcc-4677

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar: